Table 5.

Estimated health benefits for children due to RGGI (2009–2014) from the previous Abt Associates analysis [RGGI and neighboring states (Manion et al. 2017)].

Health end point	Avoided incidences	Economic value (million 2015$)
Acute bronchitis	510	0.30
Infant mortalitya	$<1$	7.30
Lower respiratory symptoms	6,500	0.17
Upper respiratory symptoms	9,300	0.37
Totalb	16,310	8.10

Note: BenMAP, Benefits Mapping and Analysis Program; RGGI, U.S. Regional Greenhouse Gas Initiative.

^aThe 2017 analysis estimated $<1$ avoided infant mortality due to RGGI. It is important to note that the C-R functions in BenMAP estimate actual health outcomes based on the change in risk of an outcome. Therefore, estimating $<1$ avoided infant mortality means that RGGI reduced the risk to infants by a relatively small, although not negligible, amount. Nevertheless, this reduced risk still has a very high economic value relative to the other health outcomes.

^bTotals may not sum due to rounding.